| Patents for C07J 53 - Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by condensation with carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms (1,809) |
|---|
| 09/11/2002 | EP1237904A2 14,15-beta-methylene substituted androgens |
| 09/04/2002 | EP1235850A1 Unsaturated 14,15-cyclopropane-androstanes, a method for their production and pharmaceutical compositions containing these compounds |
| 08/15/2002 | US20020111502 Cholic acid or deoxycholic acid derivatives can include polypeptides, polynucleotides such as genes and antisense nucleic acids that can modulate cellular activity |
| 08/15/2002 | US20020111337 Use of an aldosterone receptor antagonist to improve cognitive function |
| 08/13/2002 | US6432939 Sexual disorders |
| 07/23/2002 | US6423698 Combination therapy for the prophylaxis and/or treatment of benign prostatic hyperplasia |
| 07/17/2002 | EP1223174A2 Processes for preparation of 3-keto-7alpha-alkoxycarbonyl-delta-4,5- steroids and intermediates useful therein |
| 06/27/2002 | WO2002049622A2 Transdermal system containing a novel high potency progestagen |
| 06/26/2002 | EP1216699A1 Transdermal system comprising a highly potent progestin |
| 06/26/2002 | CN1355809A Immunomodulatory steroids, in particular hemihydrate of 16 alpha-bromoepiandrosterone |
| 06/20/2002 | WO2002048171A1 Methylene steroids as novel androgens |
| 06/19/2002 | EP1165596B1 14,15-alpha-methylene equilenine derivatives, methods for producing the same and medicaments containing them |
| 06/19/2002 | EP1056769B1 15-methyl-cyclopropanosteroids and method for the production thereof |
| 06/19/2002 | CN1354666A Lower toxicity and anti-inflammatory and anti-exudation pharmaceutical composition |
| 06/18/2002 | US6407086 Novel sterol derivatives used for regulating the meiosis in oocytes and in male germ cells |
| 06/12/2002 | EP1213026A1 Brain cell or nerve cell protecting agents comprising ginseng |
| 06/11/2002 | US6403816 Increased bioavailability and reduced toxicity |
| 05/23/2002 | US20020061868 Pharmaceutical preparations containing estra-1,3,5(10)-triene derivatives |
| 05/22/2002 | CN1350543A 14 beta-H-sterols, PHarmaceutical composiutions comprising them and use of these derivatives for the preparation of meiosis regulating medicaments |
| 05/21/2002 | US6392069 Compositions for enhancing delivery of nucleic acids to cells |
| 05/16/2002 | US20020058649 Administering during follicular phase of female menstrual cycle and in luteal phase, a competitive progesterone antagonist, which is less than an ovulation-inhibiting dose and less than an abortion-inductive dose |
| 05/14/2002 | US6388109 Hormone replacement therapy |
| 05/07/2002 | US6384025 Skin disorders; reacting retinol with chloroformate compound |
| 05/02/2002 | EP0615448B1 Sex steroid activity inhibitors |
| 04/24/2002 | CN1346364A 16-hydroxyestratrienes as selective estrogens |
| 04/18/2002 | US20020045774 Antigestagenically active steroids with a fluorinated 17-alpha-alkyl chain |
| 04/18/2002 | US20020045746 Form L crystalline eplerenone having a monoclinic crystal system and an X-ray powder diffraction pattern with a peak at 8. 0+-0.2 degrees 2 theta . |
| 04/17/2002 | EP1196427A2 Novel c-19-halogen-substituted steroids of the androst-9(11)-ene-series, methods for the production and use thereof |
| 04/17/2002 | EP0970103B1 Antigestagenic steroids with a fluorinated 17alpha-alkyl chain |
| 04/11/2002 | US20020042507 Process for preparation of 9,11-epoxy steroids and intermediates useful therein |
| 04/03/2002 | EP0986574B1 11beta-aryl substituted 14,17-ethano-oestratriens, method for the production of these compounds and their use in the production of medicaments. |
| 03/28/2002 | US20020038021 Eplerenone crystalline form exhibiting enhanced dissolution rate |
| 03/20/2002 | EP1090029B1 14,15-cyclopropanosteroids of the 19-norandrostane series, method for the production thereof and pharmaceutical preparations containing said compounds |
| 03/07/2002 | WO2002017895A2 Use of an aldosterone receptor antagonist to improve cognitive function |
| 03/07/2002 | CA2419256A1 Use of an aldosterone receptor antagonist to improve cognitive function |
| 03/06/2002 | CN1080267C Preparation of intermediat of 19, 11 beta-bridge steroid |
| 03/05/2002 | CA2056638C 2 .beta., 19-ethylene bridged steroids as aromatase inhibitors |
| 02/28/2002 | WO2002015920A2 Treatment of hyperproliferative diseases |
| 02/28/2002 | CA2419840A1 Treatment of hyperproliferative diseases |
| 02/27/2002 | CN1079666C Dermatological preparation |
| 02/14/2002 | US20020019547 Skin disorders; reacting retinol with chloroformate compound |
| 02/14/2002 | US20020019522 Steroids |
| 02/07/2002 | US20020016481 Oxireno-, azetidino-, and methano- picene derivatives |
| 02/07/2002 | US20020016455 Epoxidation of cyclopenta(a)phenanthrene derivatives |
| 02/06/2002 | EP1177205A1 14$g(b)-H-STEROLS, PHARMACEUTICAL COMPOSITIONS COMPRISING THEM AND USE OF THESE DERIVATIVES FOR THE PREPARATION OF MEIOSIS REGULATING MEDICAMENTS |
| 01/30/2002 | EP0942920B1 Steroid esters, method for the manufacture thereof and their pharmaceutical use |
| 01/23/2002 | EP1090028B1 Unsaturated 14,15-cyclopropanoandrostanes, method for the production thereof and pharmaceutical preparations containing said compounds |
| 01/23/2002 | CN1332175A Jackfruit cycloalkane triterpenic saponin as one new compound and its application in the treatment of cardiovascular disease |
| 01/22/2002 | US6340688 Administering to female during menstrual cycle amount of competitive progesterone antagonist which is less than ovulation-inhibiting dose and less than abortion-inductive dose |
| 01/15/2002 | US6339079 Steroid sulfamates, method for the production and use thereof |
| 01/09/2002 | EP1170299A2 Processes for preparation of 9,11-epoxy steroids and intermediates useful therein |
| 01/03/2002 | WO2002000682A1 16, 17-carbocyclic condensed steroid compounds having selective estrogenic activity |
| 01/02/2002 | EP1167381A2 Process for preparation of 7 alpha-carboxyl 9,11-epoxy steroids and Intermediates useful therein |
| 01/02/2002 | EP1167380A2 11.alpha.-hydroxy-steroid-4,6-dien-3-one compounds and a process for their preparation |
| 01/02/2002 | EP1167364A1 Benzopyran-containing compounds and prodrug forms thereof |
| 01/02/2002 | EP1165596A1 14,15-.alpha.-methylene equilenine derivatives, methods for producing the same and medicaments containing them |
| 01/01/2002 | US6335441 5β-cyano-substituted steroid compounds |
| 12/19/2001 | EP1163259A1 14.beta.,17-alpha-hydroxymethylandrostane derivatives as androgens |
| 12/19/2001 | EP1163256A1 Immunomodulatory steroids, in particular the hemihydrate of 16.alpha.-bromoepiandrosterone |
| 12/19/2001 | EP0717985B1 Dermatologic preparation |
| 12/18/2001 | US6331622 Processes for preparation of 9, 11-epoxy steroids and intermediates useful therein |
| 12/18/2001 | US6331535 Retinyl carbonate derivatives, preparation process and uses |
| 12/05/2001 | CN1324802A Anti-pregnancy hormone active steroid with fluorated 17 alpha-alkyl-chain |
| 11/15/2001 | WO2001040255A3 14,15-beta-methylene substituted androgens |
| 11/13/2001 | US6316432 Antigestagenically active steroids with a flourinated 17 α-alkyl chain |
| 11/06/2001 | US6313180 Steroid compounds having contraceptive and anti-osteoporosis activity |
| 10/31/2001 | EP1149841A2 Process for the production of 6B,7B;15B,16B-dimethylene-5B-hydroxy-3-oxo-17alpha-androstane-21,17-carbolactone |
| 10/31/2001 | EP1149840A2 Drospirenon (6b, 7b, 15b, 16b-Dimethylene-3-oxo-17alpha-pregn-4-ene-21, 17-carbolactone, DRSP) with less than 0,2% impurities |
| 10/24/2001 | EP1148061A2 Process for preparation of 9, 11- epoxy steroids and intermediates useful therein |
| 10/17/2001 | EP1144431A2 16-hydroxyestratrienes as selective estrogens |
| 09/13/2001 | WO2001005805A3 Novel c-19-halogen-substituted, 5-substituted, 5-substituted or 6,10 carbocyclically condensed steroids of the androst-9(11)-ene-series, methods for the production and use thereof |
| 09/07/2001 | WO2000047603A9 16-hydroxyestratrienes as selective estrogens |
| 08/08/2001 | EP0889051B1 Triterpene derivatives and remedies for liver diseases |
| 08/07/2001 | US6271403 7α-(xi-aminoalkyl)-estratrienes, process for their production, pharmaceutical preparations which contain these 7α-(xi-aminoalkyl-estratrienes as well as their use for the production of pharmaceutical agents |
| 08/02/2001 | WO2000047603A3 16-hydroxyestratrienes as selective estrogens |
| 08/02/2001 | EP1144431A3 16-hydroxyestratrienes as selective estrogens |
| 07/12/2001 | WO2001049293A1 A lower toxicity and anti-inflammatory and anti-exudation pharmaceutical composition |
| 07/11/2001 | CN1068333C Sterol derivatives used as regulation of meiosis |
| 07/10/2001 | US6258946 Chemical intermediate for diuretic |
| 07/10/2001 | US6258792 Cationic cholesteryl derivatives containing cyclic polar groups |
| 07/05/2001 | WO2001047945A1 Process for preparing 17alpha-acetoxy-11beta-[4-n,n-(dimethylamino)phenyl]-21-methoxy-19-norpregna-4,9-diene-3,20-dione, intermediates useful in the process, and processes for preparing such intermediates |
| 07/05/2001 | US20010006946 Improved gene transfer efficiency by coadministering with a cholic acid or deoxycholic acid amide derivative of given formula |
| 06/21/2001 | DE19959697A1 14,15-Cyclopropanosteroide der 19-Norandrostan-Reihe, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen 14,15-Cyclopropanosteroide the 19-norandrostane series, process for their preparation and pharmaceutical compositions containing them |
| 06/21/2001 | DE19959696A1 Ungesättigte 14,15-Cyclopropano-Androstane, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen Unsaturated 14,15-cyclopropano-androstanes, to processes for their preparation containing these compounds and pharmaceutical compositions |
| 06/14/2001 | WO2001042275A1 Unsaturated 14,15-cyclopropane-androstanes, a method for their production and pharmaceutical compositions containing these compounds |
| 06/14/2001 | WO2001042274A1 14,15-cyclopropanosteroids of the 19-norandrostane series, method for producing said compounds and pharmaceutical preparation containing said compounds |
| 06/14/2001 | US20010003782 Novel sterol derivatives used for regulating the meiosis in oocytes and in male germ cells |
| 06/07/2001 | WO2001040255A2 14,15-beta-methylene substituted androgens |
| 06/07/2001 | CA2390226A1 14,15-beta-methylene substituted androgens |
| 06/05/2001 | US6242619 19-norpregnane steroids as neurochemical initiators of change in human hypothalamic function |
| 05/09/2001 | CN1294514A Steroid derived antibiotics |
| 05/08/2001 | US6229029 11β-aryl substituted 14,17-ethanoestratriens, method for the production of these compounds and their use in the production of medicaments |
| 05/08/2001 | US6228850 Administering as antitumor and anticarcinogenic agents |
| 05/01/2001 | US6225353 Method and composition for selectively inhibiting melanoma |
| 04/11/2001 | EP1090029A1 14,15-cyclopropanosteroids of the 19-norandrostane series, method for the production thereof and pharmaceutical preparations containing said compounds |
| 04/11/2001 | EP1090028A1 Unsaturated 14,15-cyclopropanoandrostanes, method for the production thereof and pharmaceutical preparations containing said compounds |
| 04/10/2001 | US6214814 Use of betulinic acid derivatives for inhibiting cancer growth |
| 03/27/2001 | US6207403 Kinesin motor modulators derived from the marine sponge Adocia |
| 03/13/2001 | US6201018 Triterpene derivatives and remedies for liver diseases |
| 03/08/2001 | WO2001015717A1 Brain cell or nerve cell protecting agents comprising ginseng |